Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s): CPHRF

Healthcare Biotechnology

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.

TSX:CPH - Post by User

Cipher Pharmaceuticals Inc

Bullboard Posts

Comment by Stylesson Feb 11, 2014 9:51pm

108 Views

Post# 22198198

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Absurd Valuation (part 3)

i've never posted any patential stuff or studies. just been here pointing out all the bad calls you've made truthseeker.

This is the first time you actually did something right which is buying shares below 7.

Still going lower though. sorry buddy!

Bullboard Posts

Understanding different debt management strategies (good debt vs. bad debt)